SARIA

What SARIA does

SARIA SE & Co. KG is a privately held, family-owned German industrial company headquartered in Selm, Germany, operating across 26 countries with 13,000 employees. The company is structured around two divisions: SARIA Ingredients & Energy, which converts animal-origin by-products and other organic residues into recycled organic materials, rendered products, and renewable energy inputs for food processing, pharmaceutical, energy, and bio-based industries; and SARIA Food & Pharma, which supplies specialty collagen-based ingredients, edible films and coatings, and bioactive compounds to food, beverage, pharmaceutical, and nutraceutical manufacturers.

SARIA's core technology is industrial-scale circular-economy processing: collecting organic residues that would otherwise require disposal and transforming them into specification-grade ingredients and energy. Notable proprietary capabilities include collagen-based edible films and coatings (acquired via the £564M Devro plc acquisition in April 2023), CollAvant n2 native type II collagen (produced by wholly-owned subsidiary Bioiberica with clinically validated joint-health efficacy at 40mg/day), and Sustainable Aviation Fuel production under construction at Grandpuits, France via a joint development with TotalEnergies (production planned for Q4 2026).

SARIA's revenue model is primarily transaction-based B2B sales of recycled organic materials, specialty ingredients, and energy inputs under negotiated supply contracts; pricing is not publicly disclosed. Go-to-market is direct B2B sales across its 26-country footprint with regional branded websites (saria.de, saria.fr, saria.pl, saria.es, saria.at, saria.co.uk, daka.dk). Strategic customers include Lactalis (for the Puleva functional dairy launch) and TotalEnergies (SAF joint development). ESG credentials — EcoVadis Gold Medal (two consecutive years), CSRD-aligned reporting, ISO 27001-certified IT — are positioned as competitive differentiators in industrial procurement.

Name

SARIA

Legal name

SARIA SE & Co. KG

Website

https://saria.com

Company type

Private

Founded year

1970

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

SARIA is a family-owned German industrial group operating across 26 countries with 13,000 employees, specializing in circular-economy processing of animal-origin and organic residues into specialty food and pharmaceutical ingredients and renewable energy.

Ownership category

akta.pro rank

Product category

Animal By-product Rendering and Specialty Ingredients Manufacturing

NAICS

Rendering and Meat Byproduct Processing (311613), Starch and Vegetable Fats and Oils Manufacturing (31122)

SIC

Food And Kindred Products (2000), Miscellaneous Food Preparations & Kindred Products (2090)

akta.pro primary industry

Collagen, Gelatin & Protein Hydrolysates (Animal-Derived) (AFANAGAI)

akta.pro secondary industry

Hydrocolloids, Thickeners & Gelling Agents (Pectin, Xanthan, Carrageenan, Gelatin) (CRADAOAD)

Keywords

• Animal by-product processing
• Organic waste recycling
• Specialty food ingredients
• Collagen-based materials
• Sustainable aviation fuel

Headquarters

HQ city

Selm

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Ingredients & Energy (Recycling & Rendering): SARIA converts animal-origin and other organic materials into high-value ingredients and energy inputs, serving industrial customers in food processing, pharma, energy, and bio-based sectors. Revenue is generated through the sale of recycled organic materials, rendered products, and processed ingredients.
2. Food & Pharma Specialty Ingredients: SARIA Food & Pharma division sells specialty collagen-based ingredients, edible films, coatings, and bioactive compounds (such as native type II collagen from Bioiberica) to food, beverage, pharmaceutical, and dietary supplement manufacturers.
3. Edible Animal Fats & Specialty Lipids: Production and sale of edible animal fats (tallow, lard, butter segments) to bakery, confectionery, and foodservice sectors, as well as clean-label and heritage product applications. Revenue is transaction-based through supply agreements with food processors.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

SARIA converts products of animal origin and other organic materials that would otherwise be considered residues into valuable ingredients and energy inputs for the food processing, pharmaceutical, energy, and bio-based industries. The company operates two divisions — SARIA Ingredients & Energy (recycling, rendering, and waste-to-value solutions) and SARIA Food & Pharma (collagen-based edible films, coatings, and bioactive ingredients such as CollAvant n2 native type II collagen) — selling directly to industrial B2B customers.

Product overview

SARIA is a family-owned company operating in two main divisions: SARIA Ingredients & Energy and SARIA Food & Pharma. The company converts animal-origin products and organic materials into valuable inputs through circular economy processes. Key products include collagen-based ingredients (via Bioiberica subsidiary and Devro acquisition), bioactive ingredients for functional nutrition, and sustainable aviation fuel (SAF) through partnerships. Bioiberica, a life science subsidiary, specializes in native type II collagen (Collavant® n2) for joint health applications. The SAF project with TotalEnergies represents their renewable energy initiatives.

Differentiator

Problem solved

Functional benefit

Products and services

• Collagen-based Edible Films and Coatings Collagen-based edible films and coatings for food casing and packaging applications, serving food manufacturers and processors; the product line was acquired through SARIA's £564 million purchase of Devro plc in April 2023.
• CollAvant n2 (Native Type II Collagen) Native type II collagen developed and produced by Bioiberica for functional food, beverage, and dietary supplement applications supporting joint health, with clinically proven efficacy at 40mg daily intake.
• Sustainable Aviation Fuel (SAF) Sustainable Aviation Fuel produced from organic waste streams at the Grandpuits, France facility in partnership with TotalEnergies, supplying the renewable aviation fuel market; production planned for Q4 2026.
• Edible Animal Fats and Specialty Lipids Edible animal fats (tallow, lard, and butter segments) and clean-label specialty lipid ingredients supplied to bakery, confectionery, foodservice, and heritage product manufacturers.

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• LactaliscoreStrategic or Co-development Partner · 28 January 2026Bioiberica, a life science company within the SARIA Group, and Lactalis (global dairy market leader) jointly developed 'Puleva Vita Calcio Colageno', the first functional milk drink enriched with native type II collagen (CollAvant n2). The product supports joint health and represents a strategic step for SARIA/Bioiberica in functional nutrition and bioactive ingredient integration.
• TotalEnergiescoreStrategic or Co-development Partner · 1 January 2025SARIA and TotalEnergies are jointly developing a Sustainable Aviation Fuel (SAF) project at Grandpuits, France. The project entered the construction phase in 2025, with production planned for Q4 2026. The partnership converts organic waste streams into renewable jet fuel, advancing circular economy and decarbonization objectives for both parties.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Tyson Foods: US-headquartered protein processor with significant rendering and by-product operations. Overlaps with SARIA's rendering core but operates as a broad incumbent protein company rather than a circular-economy specialist.
• Neste: Global leader in renewable diesel and sustainable aviation fuel (SAF). Comparable to SARIA's SAF project with TotalEnergies at Grandpuits — establishes market benchmarks for SAF pricing, offtake dynamics, and circular feedstock economics.
• JBS: World's largest meat processor with integrated rendering and by-product valorization operations. Comparable to SARIA's rendering and recycled-organic-materials business, though broader protein focus.
• Cargill: Global agribusiness giant with rendering, animal nutrition, and bio-industrial businesses that overlap with SARIA's Ingredients & Energy division. Broader portfolio but directly competes for rendering feedstock and food/pharma ingredient customers.

Direct peers

• Darling Ingredients: The largest publicly-traded global renderer and producer of sustainable ingredients from animal by-products. Operates Diamond Green Diesel (renewable diesel) and Rousselot (collagen) — directly comparable to SARIA's Ingredients & Energy and Food & Pharma divisions.
• GELITA: Global leader in collagen and gelatin proteins for food, pharma, and health/nutrition applications. Directly competes with SARIA/Bioiberica/Devro in collagen-based ingredients and bioactive peptides.
• PB Leiner (Tessenderlo Group): Major global producer of gelatin and collagen peptides for food, pharma, and technical applications. Direct competitor in collagen-based ingredients and a key benchmark for SARIA's Devro/Bioiberica specialty ingredients business.
• Rousselot (Darling Ingredients): World's largest gelatin and collagen peptide manufacturer, owned by Darling Ingredients. Directly comparable to SARIA's collagen-based films/coatings portfolio acquired through Devro and Bioiberica's native type II collagen.
• Nitta Gelatin: Japanese gelatin and collagen peptide manufacturer with significant food, pharma, and health-nutrition presence. Direct competitor to SARIA/Devro/Bioiberica in collagen-based ingredients, particularly in Asian markets where SARIA is expanding.

Emerging players

• Bio-Techne: Life sciences tools and bioactive ingredients provider with strong presence in joint-health, regenerative medicine, and functional nutrition adjacencies. Comparable to Bioiberica's CollAvant n2 bioactive collagen ingredient portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/sariafrance
• LinkedInlinkedin.com/company/saria-a-s-gmbh

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SARIA